We are live on ! Find out more
SIOX

Sio Gene Therapies Inc. Common Stock
SIOX

Delisted

SIOX was delisted on the 22nd of March, 2023.

Back to rankings

62 hedge funds and large institutions have $39.7M invested in Sio Gene Therapies Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 16 increasing their positions, 8 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 8

80% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 15

27% more call options, than puts

Call options by funds: $1.71M | Put options by funds: $1.35M

24% more funds holding

Funds holding: 50 → 62 (+12)

24% less capital invested

Capital invested by funds: $52.3M → $39.7M (-$12.6M)

Holders
62
Holders Change
+12
Holders Change %
+24%
% of All Funds
1.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
27
Increased
16
Reduced
8
Closed
15
Calls
$1.71M
Puts
$1.35M
Net Calls
+$360K
Net Calls Change
+$780K

Top Buyers

Rank Fund Capital Flow
1
RCMNY
Rubric Capital Management (New York)
New York
+$5.46M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$3.21M
3
SCM
Sio Capital Management
New York
+$2.58M
4
Morgan Stanley
Morgan Stanley
New York
+$1.02M
5
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
+$801K

Top Sellers

Rank Fund Capital Flow
1
SFM
Sphera Funds Management
Israel
-$5.33M
2
CA
Corriente Advisors
Texas
-$4.04M
3
Renaissance Technologies
Renaissance Technologies
New York
-$2.04M
4
Two Sigma Investments
Two Sigma Investments
New York
-$1.42M
5
IC
Ikarian Capital
Texas
-$820K
Name Holding Trade Value Shares
Change 		Change in
Stake
CM
26
Caption Management
Oklahoma
$125K +$131K +45,000 New
Squarepoint
27
Squarepoint
New York
$118K +$123K +42,388 New
DMK
28
David M. Knott
$111K +$116K +40,000 New
Simplex Trading
29
Simplex Trading
Illinois
$105K -$30.2K -10,381 -22%
Wells Fargo
30
Wells Fargo
California
$100K +$105K +35,984 +27,469%
CL
31
CSS LLC
Illinois
$99K +$97.1K +33,349 +1,543%
PCM
32
Prelude Capital Management
New York
$95K – – –
Dimensional Fund Advisors
33
Dimensional Fund Advisors
Texas
$93K +$45.5K +15,628 +87%
ECM
34
ExodusPoint Capital Management
New York
$88K +$92.5K +31,777 New
IA
35
Insight Advisors
Pennsylvania
$67K +$69.9K +24,000 New
SM
36
SG3 Management
Puerto Rico
$63K +$65.5K +22,500 New
CAC
37
Cowen and Company
New York
$53K +$55.3K +19,000 New
TRCT
38
Tower Research Capital (TRC)
New York
$51K +$53.3K +18,291 +121,940%
N
39
Natixis
France
$44K +$46.6K +16,000 New
Royal Bank of Canada
40
Royal Bank of Canada
Ontario, Canada
$39K -$2.13K -732 -5%
Jane Street
41
Jane Street
New York
$32K +$33.7K +11,588 New
UBS Group
42
UBS Group
Switzerland
$26K +$15.3K +5,245 +126%
LC
43
Lindbrook Capital
California
$11K -$25.9K -8,901 -68%
ASN
44
Advisory Services Network
Georgia
$11K +$11.6K +4,000 New
IAIM
45
International Assets Investment Management
Florida
$8K +$8.73K +3,000 New
TWA
46
TCI Wealth Advisors
Arizona
$7K +$7.28K +2,500 +2,500%
FDCDDQ
47
Federation des caisses Desjardins du Quebec
Quebec, Canada
$6.39K – – –
CG
48
Cutler Group
California
$5K +$5.82K +2,000 New
Osaic Holdings
49
Osaic Holdings
Arizona
$3K +$2.93K +1,006 +1,258%
Northwestern Mutual Wealth Management
50
Northwestern Mutual Wealth Management
Wisconsin
$2K +$2.18K +750 New
1
2
3

SIOX Hedge Fund Activity: Q4 2020 in Review

62 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Sio Gene Therapies Inc. Common Stock (SIOX) for Q4 2020, worth a combined $39.7M — down 24% from $52.3M a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new SIOX positions and 15 closed out — a net gain of 12 holders — while 16 added to existing stakes and 8 trimmed.

The largest buyer was Rubric Capital Management (New York), adding an estimated $5.46M. The largest seller was Sphera Funds Management, exiting entirely with an estimated $5.33M sold.

  • 62 institutional investors held Sio Gene Therapies Inc. Common Stock (SIOX) as of Q4 2020, up from 50 in Q3 2020.
  • Funds reported $39.7M of Sio Gene Therapies Inc. Common Stock stock for Q4 2020, down 24% quarter-over-quarter.
  • 27 funds opened new Sio Gene Therapies Inc. Common Stock positions in Q4 2020 and 15 closed out, a net change of +12 holders.
  • The largest Sio Gene Therapies Inc. Common Stock buyer in Q4 2020 was Rubric Capital Management (New York), an estimated $5.46M added.
  • The largest Sio Gene Therapies Inc. Common Stock seller in Q4 2020 was Sphera Funds Management, an estimated $5.33M sold.

Based on aggregated 13F filings for Q4 2020.